Funder: Gilead Sciences
Due Dates (Anticipated): September 2026 (RFP Letter of Interest deadline, projected)
Funding Amounts: Typically $180,000 per award over 2 years; 3–4 awards per cycle expected.
Summary: Supports impactful oncology research proposals to advance clinical decision-making and patient outcomes.
Key Information: This is a forecasted opportunity; no current RFP is open—dates and details may change.